Clin2
NCT07054918Worth exploringNot yet recruiting

Isolated positive toxoplasma blood test without symptoms

Toxoplasmosis

Part of Infections clinical trials.

This study looks at people who have a positive toxoplasma blood test (PCR) but no symptoms. It aims to learn more about what this finding means and how it should be treated.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
Any age
Study type
Observational

Who can take part

  • You have a positive toxoplasma PCR (genetic test) in your blood, but no symptoms of toxoplasmosis since your last negative blood test.
  • You have not had a positive toxoplasma test in any other body sample (like spinal fluid or saliva) in the last 6 weeks.
  • You are known to be immune to toxoplasmosis (you have had it before), not someone with unknown immunity or no prior exposure.
  • No blood test results suggesting a new, active toxoplasma infection (acute toxoplasmosis).
  • You do not have toxoplasmosis affecting your eyes, toxoplasmosis from birth, or toxoplasmosis related to HIV/AIDS.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06305468Recruiting
Toxoplasmosis prognosis in ICU patients diagnosed by PCR

This study looks at how people with severe toxoplasmosis (a parasitic infection) that affects the brain or spreads in the body, and who need intensive care, recover. It uses a sensitive test called PCR to confirm the infection.

Paris, France
NCT07346833Recruiting
MicroRNA in women with toxoplasmosis and mental illness

This study looks at tiny molecules in the blood (called microRNAs) that might help doctors tell the difference between mental health conditions in women who have had a past infection with the parasite Toxoplasma. The goal is to find better ways to diagnose and treat these conditions.

Banhā, El Qalyoubia
NCT00004317Recruiting· Phase 4
Treating Congenital Toxoplasmosis With Three Medications

This study tests a combination of three medications (pyrimethamine, sulfadiazine, and leucovorin) to treat toxoplasmosis—a parasitic infection passed from mother to baby during pregnancy. The goal is to see if early treatment prevents serious complications in infected infants.

Chicago, Illinois
NCT04271397Recruiting
Testing immune blood markers in tuberculosis care

This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.

Lyon
NCT07299500Recruiting
Toxoplasmosis study in non-HIV immune compromised patients

This study looks at toxoplasmosis infections in people with weakened immune systems (not caused by HIV). It aims to learn more about how these infections happen and how they affect patients.

Strasbourg
NCT04474132Recruiting
Testing for current or past Toxoplasmosis infection

This study checks whether a simple “point-of-care” test can detect current or past Toxoplasmosis infection (a common germ). Your results may help evaluate how well the test works and how it could be used in care.

Chicago, Illinois

Hear when a new Toxoplasmosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.